TY - JOUR T1 - The autumn COVID-19 surge dates in Europe are linked to latitudes and not to temperature, nor to humidity, pointing vitamin D as a contributing factor JF - medRxiv DO - 10.1101/2020.10.28.20221176 SP - 2020.10.28.20221176 AU - Stephan Walrand Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/02/2020.10.28.20221176.abstract N2 - Purpose Determining the triggering factor of the sudden surge of the daily new COVID-19 cases arising in most European countries during 2020 Autumn.Methods The dates of the surge were determined using a fitting of the two last months reported daily new cases in 18 European countries of latitude ranging from 39° to 62°.Results The study proves no correlation between the country surge date and its 2 weeks preceding temperature or humidity, but shows an impressive linear correlation with its latitude. The country surge date corresponds to the time when its sun UV daily dose drops below ≈ 34% of that of 0° latitude. Introducing reported seasonal blood 25-hydroxyvitamin D (25(OH)D) concentration variation into reported link between acute respiratory track infection risk with 25(OH)D concentration quantitatively explains the surge dynamics.Conclusions Several studies already substantiated a 25(OH)D concentration impact on COVID-19 severity. However by comparing different patients populations, discriminate whether low 25(OH)D concentration is a real factor of covid-19 severity or only a marker of another weakness being the primary severity factor can be challenging. The date of the surge is an intrapopulation observation and has the benefit to be only triggered by a parameter globally affecting the population, i.e. the sun UV daily dose decreases. The results support that low 25(OH)D concentration is thus well a contributing factor of COVID-19 severity, which joined with the previous studies makes a convincing bundle of evidenceCompeting Interest StatementThe authors have declared no competing interest.Funding StatementnoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A all data used come from open databaseAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data referred in the paper come from open database ER -